< Back to companies

A Prague-based biotechnological start-up Elphogene, sro which has been founded as a spin-off from the Genomac Research Institute introduced a project oncoMonitor™ for monitoring circulating tumor DNA (referred to as ctDNA) in cancer patients in 2019. oncoMonitor™ is a new diagnostic tool based on liquid biopsy – screening of ctDNA in blood of peripheral cancer patients. It was developed in the Czech Republic based on ten years of research and collaboration with leading oncology centers. The purpose of oncoMonitor™ is a follow-up of patients in advanced stages of cancer for early detection of newly arising metastatic lesions. The technology is capable of capturing ctDNA in up to 88% of patients with advanced colorectal cancer with the presence of liver metastases.

Share
Shareable draft
Get Involved in ELPHOGENE

Company Info

Founded
2018
Website
www.elphogene.cz/

Categories

Cancer CareScreening & Early DetectionDiagnosticsMolecular Diagnostics

Disease Areas

Technologies

Cell-Free DNA (cfDNA) AnalysisMolecular DiagnosticsDiagnostic PlatformsDiagnostics
Only accessible to MedStartr community members. Join now

What do you think of ELPHOGENE?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in ELPHOGENE
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free